Valuation: Circio Holding ASA

Market Cap 2.79B 294M 258M 243M 222M 415M 28.16B 418M 2.91B 1.13B 14.39B 1.1B 1.08B 46.23B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 2.79B 294M 258M 244M 222M 416M 28.18B 419M 2.92B 1.13B 14.4B 1.1B 1.08B 46.27B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
73.72%
Yield 2024 *
-
Yield 2025 -
1 day-0.59%
1 week-7.68%
Current month-21.83%
1 month-23.48%
3 months+35.57%
6 months-1.37%
Current year+767.70%
1 week 9.96
Extreme 9.96
11.2
1 month 9.96
Extreme 9.96
15.7
Current year 0.98
Extreme 0.978
15.7
1 year 0.59
Extreme 0.59
15.7
3 years 0.48
Extreme 0.48
15.7
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 2021-10-19
Director of Finance/CFO 58 2022-03-06
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 79 2015-06-30
Director/Board Member 66 2015-09-13
Chairman 64 2020-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
11/30/21 Exercice

Chief Executive Officer

120,000 0.1386%
5/19/21 Buy

Director

21,299 0.0246%
12/3/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%-7.68%+1,555.74%-9.01% 294M
-3.30%+1.50%+57.79%+85.24% 72.26B
+0.31%-2.33%+38.71%+87.61% 60.24B
+1.04%+0.94%+35.10%+21.32% 27.73B
-3.06%-1.81%-14.01%+354.94% 25.73B
-0.75%+2.56%+0.45%-4.46% 24.75B
+1.52%+0.75%+23.72%-9.50% 20.74B
-1.70%-2.12%+150.24%+323.16% 15.06B
+0.36%-0.34%+48.98%+162.10% 14.41B
-2.66%-8.27%-8.27%+482.82% 14.23B
Average -0.90%-1.01%+188.84%+149.42% 27.54B
Weighted average by Cap. -1.16%+0.29%+39.69%+126.79%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.06M 5.31M 5.02M 4.57M 8.56M 580M 8.62M 60.07M 23.26M 297M 22.74M 22.25M 953M -45.91M -4.83M -4.24M -4.01M -3.65M -6.83M -463M -6.88M -47.94M -18.57M -237M -18.15M -17.76M -761M
Net Debt -972K -102K -89.81K -84.82K -77.3K -145K -9.81M -146K -1.01M -393K -5.01M -384K -376K -16.11M 2.24M 236K 207K 196K 179K 334K 22.66M 337K 2.34M 908K 11.57M 888K 868K 37.2M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
11
Date Price Change Volume
26-09-28 NOK 10.10 -0.59% 123,873
26-09-25 NOK 10.16 -1.74% 3,953,975
26-09-24 NOK 10.34 -2.08% 4,927,209
26-09-23 NOK 10.56 +0.76% 5,836,833
26-09-22 NOK 10.48 -4.20% 10,242,365

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock